CID 135499596

2-[(6-methylimidazo[2,1-b]thiazole-5-yl)carbonyl]thydrazono-4-thiazolidinone.

Structural Information

Molecular Formula
C10H9N5O2S2
SMILES
CC1=C(N2C=CSC2=N1)C(=O)N/N=C/3\NC(=O)CS3
InChI
InChI=1S/C10H9N5O2S2/c1-5-7(15-2-3-18-10(15)11-5)8(17)13-14-9-12-6(16)4-19-9/h2-3H,4H2,1H3,(H,13,17)(H,12,14,16)
InChIKey
GQQSEXVBQQZOFT-UHFFFAOYSA-N
Compound name
6-methyl-N-[(E)-(4-oxo-1,3-thiazolidin-2-ylidene)amino]imidazo[2,1-b][1,3]thiazole-5-carboxamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

295.01978 Da
Monoisotopic Mass

2.2
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 296.02706 163.2
[M+Na]+ 318.00900 174.6
[M-H]- 294.01250 169.2
[M+NH4]+ 313.05360 182.0
[M+K]+ 333.98294 170.8
[M+H-H2O]+ 278.01704 158.2
[M+HCOO]- 340.01798 177.9
[M+CH3COO]- 354.03363 175.4
[M+Na-2H]- 315.99445 161.6
[M]+ 295.01923 166.8
[M]- 295.02033 166.8
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.